Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Sparta licenses drug delivery technology for temozolomide to Schering-Plough

April 27, 1998

Pacific will begin safety trial of BOPP photodynamic therapy

April 27, 1998

Immunosuppressive MDR inhibitor isolated from bacterial species

April 24, 1998

Kyowa Hakko develops new antitumor agents from DC-89

April 24, 1998

GnRH antagonists for sex hormone-related disorders described by Takeda

April 24, 1998

Nippon Kayaku discloses new antiproliferative compound produced by bacterial species

April 24, 1998

Maximum androgen blockade is superior to orchiectomy in prostate cancer

April 24, 1998

Gelatinase inhibitor with antitumor activity disclosed by Banyu

April 23, 1998

Roche discloses antiproliferative substituted pyrroles

April 23, 1998

Hypoxia in solid tumors: a new target for selective tumor therapy

April 22, 1998

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...